Advertisement

Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: A Study of 252 Patients

  • C. Jacquillat
  • M. Weil
  • G. Auclerc
  • M.-F. Auclerc
  • D. Khayat
  • F. Baillet
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 115)

Abstract

Concepts concerning breast cancer have been considerably modified during the last 10 years. From the concept of a local disease with secondary metastases, the thinking has changed to that of a two-component disease: local on the one hand, and generalized on the other, the latter being more critical the larger the tumor size, the faster the tumor growth rate, the greater the lymph node involvement, and the less the differentiation on histological or nuclear grading.

Keywords

Breast Cancer Clin Oncol Advanced Breast Cancer Tumor Regression Operable Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonadonna G, Valagussa P (1985) Adjuvant systemic therapy for resectable breast cancer. Clin Oncol 3 (2): 259–275Google Scholar
  2. Calle R, Pilleron JP (1979) Radiation therapy for operable breast cancer. 10 years results. Breast 5: 2–6Google Scholar
  3. Canellos GP (1984) The treatment of locally advanced breast cancer. Clin Oncol 2 (3): 149–151Google Scholar
  4. Chauvergne J, Durand M, Hoerni B, Cohen P, Lagarde C (1979) La chimiothérapie d’induction dans les cancers du sein à haut risque: Résultats d’une étude thérapeutique prospective. Bull Cancer (Paris) 66: 9–16Google Scholar
  5. Ferguson DJ, Meier P, Karrison J, Dawson PJ, Straus FH, Lowenstein FG (1982) Staging of breast cancer and survival rates. JAMA 248: 1337–1341PubMedCrossRefGoogle Scholar
  6. Fisher B, Redmond C, Eias G, Evans J et al. (1982) Adjuvant chemotherapy of breast cancer: an overview of NSABP findings. Adv Surg Oncol 5: 65–90Google Scholar
  7. Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733PubMedGoogle Scholar
  8. Jacquillat C, Baillet F, Auclerc G et al. (1982) Initial chemotherapy and conservative radiotherapy in stage I, II and III breast cancer. Proceedings 13th International Cancer Congress, Seattle, pp 52 (abstract 3218)Google Scholar
  9. Jacquillat C, Baillet F, Blondon J et al. (1983) Preliminary results of “neo-adjuvant” chemotherapy in initial management of breast cancer (BC). Proceedings ASCO, San Diego, 112 (abstract C 437)Google Scholar
  10. Jacquillat C, Baillet F, Auclerc G et al. (1984a) Cancer du sein: chimiothérapie précédant le traitement loco-régional avec extension des indications du traitement conservateur. Bull Cancer (Paris) 71 (4): 354–360Google Scholar
  11. Jacquillat C, Auclerc G, Baillet F et al. (1984b) Chimiothérapie première dans le cancer du sein: Résultats préliminaires. Ann Med Interne (Paris) 135 4: 1–295Google Scholar
  12. Jacquillat C, Weil M, Auclerc G et al. (1985) Neoadjuvant chemotherapy in the conservative management of breast cancer. Study on 205 patients. Proc 1st Int Congress on neoadjuvant chemotherapy. Libbey, ParisGoogle Scholar
  13. Jacquillat C, Baillet F, Weil M et al. (1988) Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation. Cancer 61: 1977–1982PubMedCrossRefGoogle Scholar
  14. Kantarjian HP, Hortobagyi GN, Smith TL, Blumenschein GR, Montague E, Buzdar AU, Martin RG (1984) The management of locally advanced breast cancer, a combined modality approach. Eur J Cancer Clin Oncol 20: 1353–1361PubMedCrossRefGoogle Scholar
  15. Karrer K, Humphreys SR, Goldin A (1967) An experimental model for studying factors which influence metastases of malignant tumors. Int J Cancer 2: 213PubMedCrossRefGoogle Scholar
  16. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T (1978) Surgical adjuvant chemotherapy: results of one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41: 2088–2098PubMedCrossRefGoogle Scholar
  17. Otmezguine Y, Martin A, Le Bourgeois JP, Maylin C, Raynal M, Sallé M, Pierquin B (1980) Etude des récidives parmi 202 cancéreuses du sein traitées conservativement par radiothérapie. J Eur Radiother 1: 115–130Google Scholar
  18. Papaiannou AN (1981) Pre-operative chemotherapy for operable breast cancer. Eur J Cancer 17: 263–269CrossRefGoogle Scholar
  19. Rubens RD, Seston S, Tong D (1980) Combined chemotherapy and radiotherapy for locally advanced breast cancer. Eur J Cancer 16: 351–356PubMedCrossRefGoogle Scholar
  20. Schabel FM, Griswold DP, Corbett TH, Laster Jr, Dykes DJ, Rose WC (1979) Recent studies with adjuvant chemotherapy or immunotherapy of metastatic solid tumors of mice. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer. Grune and Stratton, New York, pp 3–17Google Scholar
  21. Tancini G, Bonadonna G, Valagussa P et al. (1983) Adjuvant CM F in breast cancer, comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1: 1–10Google Scholar
  22. Zylberberg B, Salat-Baroux J, Ravina JH, Dormont D, Amiel JP, Dielbold P, Izrael V (1982) Initial chemoimmunotherapy in inflammatory carcinoma of the breast cancer 49: 1537–1543Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1989

Authors and Affiliations

  • C. Jacquillat
    • 1
  • M. Weil
    • 1
  • G. Auclerc
    • 1
  • M.-F. Auclerc
    • 1
  • D. Khayat
    • 1
  • F. Baillet
    • 1
  1. 1.Department of Medical Oncology (SOMPS)Hôpital de la SalpétrièreParisFrance

Personalised recommendations